Castle Biosciences, Inc. Common Stock CSTL
i
Market dataready · fetched 2026-11-11T14:49:06.012Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T14:48:43.66603931Z
FundamentalsSEC EDGAR · ready · as of 2026-09-30 · fetched 2026-11-11T14:49:05.047010+00:00
Castle Biosciences, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 39.45 | 85.0% | 15.6% | 30.82 | 89.7% | 12.8% |
| 25Δ | 38.63 | 81.0% | 13.6% | 31.51 | 90.3% | 11.5% |
| 30Δ | 37.82 | 77.1% | 11.6% | 32.20 | 90.9% | 10.3% |
| 35Δ | 37.01 | 73.1% | 9.7% | 32.88 | 91.6% | 9.0% |
| 40Δ | 36.19 | 69.1% | 7.7% | 33.57 | 92.2% | 7.8% |
| 45Δ | 35.38 | 65.1% | 5.7% | 34.26 | 92.9% | 6.5% |
| 50Δ | 34.66 | 65.1% | 4.5% | 34.95 | 93.5% | 5.3% |
| 55Δ | 34.01 | 68.5% | 4.1% | |||
| 60Δ | 33.36 | 71.9% | 3.6% | |||
| 65Δ | 32.71 | 75.4% | 3.1% | |||
| 70Δ | 32.07 | 78.8% | 2.7% | |||
| 75Δ | 31.42 | 82.2% | 2.2% | |||
| 80Δ | 30.77 | 85.7% | 1.7% | |||
20Δ
- Pseudo strike
- 39.45
- IV
- 85.0%
- B/E move
- 15.6%
- Pseudo strike
- 30.82
- IV
- 89.7%
- B/E move
- 12.8%
25Δ
- Pseudo strike
- 38.63
- IV
- 81.0%
- B/E move
- 13.6%
- Pseudo strike
- 31.51
- IV
- 90.3%
- B/E move
- 11.5%
30Δ
- Pseudo strike
- 37.82
- IV
- 77.1%
- B/E move
- 11.6%
- Pseudo strike
- 32.20
- IV
- 90.9%
- B/E move
- 10.3%
35Δ
- Pseudo strike
- 37.01
- IV
- 73.1%
- B/E move
- 9.7%
- Pseudo strike
- 32.88
- IV
- 91.6%
- B/E move
- 9.0%
40Δ
- Pseudo strike
- 36.19
- IV
- 69.1%
- B/E move
- 7.7%
- Pseudo strike
- 33.57
- IV
- 92.2%
- B/E move
- 7.8%
45Δ
- Pseudo strike
- 35.38
- IV
- 65.1%
- B/E move
- 5.7%
- Pseudo strike
- 34.26
- IV
- 92.9%
- B/E move
- 6.5%
50Δ
- Pseudo strike
- 34.66
- IV
- 65.1%
- B/E move
- 4.5%
- Pseudo strike
- 34.95
- IV
- 93.5%
- B/E move
- 5.3%
55Δ
- Pseudo strike
- 34.01
- IV
- 68.5%
- B/E move
- 4.1%
- Pseudo strike
- IV
- B/E move
60Δ
- Pseudo strike
- 33.36
- IV
- 71.9%
- B/E move
- 3.6%
- Pseudo strike
- IV
- B/E move
65Δ
- Pseudo strike
- 32.71
- IV
- 75.4%
- B/E move
- 3.1%
- Pseudo strike
- IV
- B/E move
70Δ
- Pseudo strike
- 32.07
- IV
- 78.8%
- B/E move
- 2.7%
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- 31.42
- IV
- 82.2%
- B/E move
- 2.2%
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- 30.77
- IV
- 85.7%
- B/E move
- 1.7%
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 63.60% | |
| 62.68% | |
| 59.43% | |
| 60.95% | |
| 64.25% | |
| 65.20% | |
| 64.87% | |
| 63.70% | |
| 65.55% | |
| 66.34% |
Diagnostics & Research
DGX
Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains…
More →DHR
Danaher Corporation is an American globally diversified conglomerate with its headquarters in Washington, D.C.. The company designs, manufactures, and markets professional,…
More →FLGT
Fulgent Genetics, Inc., provides COVID-19 testing and genetic testing services to physicians with clinically actionable diagnostic information. The company is headquartered in…
More →GH
Guardant Health, Inc., a precision oncology company, offers blood testing, data sets, and testing in the United States and internationally. The company is headquartered in Redwood…
More →GRAL
GRAIL, LLC is a leading biotechnology firm specializing in advanced cancer diagnostics, particularly through its innovative blood tests designed for multi-cancer early detection…
More →ICLR
Description unavailable
More →